1. Introduction
In recent years, with the advancement of space exploration and long-term microgravity research, sports scientists have increasingly focused on the effects of weightlessness on muscles and bones. Studies have shown that weightlessness can lead to alterations in the structure and function of skeletal muscles, particularly anti-gravity muscles, including muscle atrophy, changes in muscle fiber types, and reduced motor function [
1], which can further impair overall health. Consequently, the development of effective interventions to mitigate or reverse the adverse effects of weightlessness on muscles has become a key area of focus in sports science research.
The ketogenic diet (KD) is characterized by high fat, moderate protein, and very low carbohydrate intake [
2,
3]. Ketone bodies, such as β-hydroxybutyrate (β-HB) and acetoacetate [
4], serve as alternative energy sources for muscles, thereby enhancing muscle endurance and strength, which ultimately improves exercise performance [
5,
6]. Studies have indicated that a ketogenic diet may positively influence muscle adaptations, promoting muscle remodeling in response to metabolic stress. These changes may involve a shift in muscle fiber type, a process critical for enhancing muscle endurance and function [
7]. For instance, Wallace et al. [
8] demonstrated that a ketogenic diet significantly improved the muscle mass and function of 26-month-old aged mice. The reduction in the area of IIb muscle fibers and the concomitant increase in the area of IIa muscle fibers suggest that long-term ketogenic diet intervention can effectively alleviate muscular dystrophy, a muscle disorder linked to decreased muscle strength and aging. Similarly, Ogura et al. [
9] confirmed this finding, showing that the ketogenic diet maintained muscle mass in sedentary mice and induced a transition in muscle heavy chain myosin (MyHC) from type IIb to type IIx fibers.
Studies have demonstrated that regular aerobic exercise can effectively mitigate muscle atrophy and induce metabolic changes in muscle cells, thereby enhancing exercise capacity [
10]. Furthermore, multiple animal studies have shown that ketogenic diets administered for 5 weeks [
11], 8 weeks [
12], and 12 weeks [
13] can improve endurance performance. However, there are currently no studies addressing the potential of combining exercise with nutritional support to combat muscle atrophy in a weightless environment, nor have such interventions been proposed as non-pharmacological strategies to restore muscle homeostasis. Notably, PGC-1α [
14,
15,
16,
17] is a key molecule in skeletal muscle that regulates oxidative metabolism, fatty acid oxidation, and the transition between fast and slow muscle fiber types. PGC-1α plays a critical role in systemic ketone body homeostasis, particularly during fasting, cold exposure, and intense exercise [
18]. Additionally, PGC-1α promotes the adaptation of ketolytic capacity during long-term exercise training [
18]. Research has shown that the FGF21-SIRT1-AMPK-PGC-1α signaling pathway facilitates muscle cell differentiation and the conversion of anaerobic muscle fibers to oxidative phenotypes [
19], thereby improving muscle aerobic capacity. Studies have also indicated that both aerobic exercise and ketogenic diets can enhance PGC-1α expression in skeletal muscle. Based on these findings, it can be speculated that the combination of a ketogenic diet and aerobic exercise in a weightless environment may produce a synergistic effect on skeletal muscle adaptation. However, to date, no studies have examined the combined effects of a ketogenic diet and aerobic exercise in a weightless environment.
Based on the aforementioned background, we hypothesize that under simulated weightlessness conditions, the combination of a ketogenic diet and aerobic exercise will effectively enhance skeletal muscle mass and exercise capacity in mice. This effect may be mediated by the regulation of muscle fiber type and metabolic pathways. Through this study, we aim to elucidate the combined effects of a ketogenic diet and aerobic exercise on skeletal muscle adaptability and provide a novel theoretical foundation and practical guidance for future research in the fields of aerospace medicine, sports medicine, and nutrition. Therefore, this study intends to use 7-week-old C57BL/6J mice to investigate the effects of an 8-week ketogenic diet combined with aerobic exercise on skeletal muscle fiber type and exercise capacity in mice subjected to simulated weightlessness. The ultimate goal is to provide scientific evidence for the development of intervention strategies targeting weightlessness-induced muscle atrophy.
2. Materials and Methods
2.1. Animals and Diets
Seven-week-old C57BL/6J mice, weighing 20–25 g, were obtained from Beijing Vital River Laboratory Animal Technology Co., Ltd., and housed in the animal facility. The mice were grouped into cages with 4–5 animals per cage, with environmental conditions maintained at a temperature of 20–24°C, relative humidity of 45%–55%, and a 12-hour light/dark cycle. All experimental protocols were approved by the Ethics Committee of the Aerospace Medicine National Key Laboratory (approval number: ACC-IACUC-2021-010).
After a 1-week acclimatization period, the mice were randomly assigned to the following experimental groups: Normal Diet Control (NC, n = 8), Normal Diet + Hindlimb Unloading (NH, n = 12), Normal Diet + Hindlimb Unloading + Exercise (NHE, n = 14), Ketogenic Diet Control (KC, n = 8), Ketogenic Diet + Hindlimb Unloading (KH, n = 12), and Ketogenic Diet + Hindlimb Unloading + Exercise (KHE, n = 14). The normal diet group was fed a standard diet (AIN93G, Shanghai Puloteng Biotechnology Co., Ltd.), consisting of 7% fat, 17.8% protein, and 64.3% carbohydrate, providing 3.601 kcal/g. The ketogenic diet group received a ketogenic feed (TP-201450, Beijing BioPeak Biotechnology Co., Ltd.), consisting of 76.1% fat, 8.9% protein, and 3.5% carbohydrate, providing 4.056 kcal/g. All mice had ad libitum access to food and water. Mice were weighed every Sunday morning between 9:00 and 10:00 AM, followed by tail vein blood collection. Blood glucose and blood ketone concentrations were measured using Yuejia-type glucose/ketone test strips. A schematic overview of the experimental design is presented in
Figure 1.
2.2. Simulated Weightlessness Model
For the final 2 weeks, mice in the NH, NHE, KH, and KHE groups underwent hindlimb unloading (HU) to establish a simulated microgravity model. The tail suspension method was employed, where a piece of medical adhesive tape was applied 2–3 cm from the tip of the mouse's tail to attach it to an iron chain, which was then suspended in a smooth-walled cage. This setup caused the hindlimbs to hang freely while the forelimbs remained on the ground, positioning the body at a 30° angle relative to the horizontal plane. Mice were housed individually in cages, allowing for free movement. The tail and blood flow were monitored regularly, and the suspension height was adjusted as necessary to maintain the optimal angle.
2.3. Training Protocols
The aerobic treadmill exercise intervention protocol was designed based on the experimental setup by Ma et al. [
12]. Mice in the NHE and KHE groups underwent a 3-day adaptation period, during which they exercised on the treadmill at 5 m/min for 10 minutes per day, with a treadmill incline of 0°. During the formal training phase, the mice performed a 10-minute warm-up at 2 m/min, followed by 60 minutes of continuous exercise at 12 m/min. The exercise regimen involved 6 days of training per week over a duration of 8 weeks. In the final 2 weeks, the NHE and KHE groups underwent exercise intervention using a rat model of simulated microgravity on the treadmill, as developed by Wang et al. [
20].
2.4. Respiratory Exchange Eatio Test
Before and after hindlimb unloading, respiratory metabolism was assessed in all mice using a GT-1000 pump-driven composite gas analyzer (Shenzhen Kerano Electronics Technology Co., Ltd., China). Mice were placed in activity chambers, where they were allowed to move freely. Measurements commenced once the mice reached a stable resting state and continued until the CO2 concentration approached 5000 ppm. During this period, changes in O2 and CO2 levels, as well as the test duration, were recorded. The resting respiratory exchange ratio (RER) was calculated using the following formula: RER = VCO2/VO2.
2.5. Assessment of Endurance Exercise Performance
Prior to the exercise capacity test, all mice underwent 1 week of acclimatization to treadmill exercise at 15 m/min for 10 minutes per day. The exercise capacity test was adapted from the study by Dougherty et al. [
21] with minor modifications. The protocol was as follows: the initial speed was set to 14 m/min for 2 minutes, followed by 16 m/min for 3 minutes, 18 m/min for 25 minutes, 20 m/min for 15 minutes, 22 m/min for 15 minutes, 24 m/min for 15 minutes, and 26 m/min for 30 minutes. The test continued until exhaustion, which was defined by the following criteria: (1) the mouse could not maintain the current running speed; and (2) mechanical or electrical stimulation for more than 10 seconds could not induce further exercise [
22].
2.6. Tissue Sampling
Immediately after the exercise endurance test, the mice were weighed and anesthetized with sodium pentobarbital. Blood was collected via the retro-orbital sinus, centrifuged to obtain serum, and stored at -20°C for future analysis. The left soleus muscle was excised, weighed to determine its wet muscle mass, and placed in a cryovial. It was then preserved in liquid nitrogen before being transferred to an ultralow freezer at -80°C for storage. The right soleus muscle was embedded in optimal cutting temperature (OCT) compound, rapidly frozen in liquid nitrogen, and stored for subsequent sectioning and staining.
2.7. Plasma Biochemical Assessment
Serum levels of triglycerides (TG), total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), insulin, creatine kinase (CK), lactate dehydrogenase (LDH), blood urea nitrogen (UREA), and blood lactate (BLA) were measured using an automated biochemical analyzer (Huake Bio, China). All procedures were conducted in strict accordance with the manufacturer's instructions provided by the reagent kits (Nanjing Jiancheng Bioengineering Institute, China).
2.8. Oil Red O Staining
The OCT-embedded tissue samples were retrieved from liquid nitrogen and sectioned to a thickness of 8 µm using a cryostat (Leica, Wetzlar, Germany). The sections were mounted onto slides, with six sections per tissue sample, and placed in a slide box. The slides were stored at -20°C until further use. Lipid staining was performed following the instructions provided by the Oil Red O Staining Kit (Beijing Solarbio Science & Technology Co., Ltd.). Tissue sections were initially washed in 60% isopropanol for 2 minutes, followed by staining with the Oil Red O working solution for 2-5 minutes. After staining, the sections were rapidly differentiated in 60% isopropanol and washed with distilled water. Subsequently, the sections were counterstained with hematoxylin for 30 seconds, differentiated with acid alcohol for 1-5 seconds, and rinsed under running water until a blue color was achieved. Finally, the sections were mounted with glycerol gelatin and observed under a light microscope, with images captured.
2.9. Periodic Acid-Schiff (PAS) Staining
The prepared frozen sections were retrieved and sequentially stained with periodic acid, Schiff's reagent, and hematoxylin, in accordance with the instructions provided in the Periodic Acid-Schiff (PAS) Staining Kit (Beijing Solarbio Science & Technology Co., Ltd.). Following washing and dehydration, the sections were mounted with neutral gum. The tissue sections were observed under an optical microscope, and images were captured and saved.
2.10. Western Blotting
Total protein was extracted from soleus muscle tissue using RIPA lysis buffer, and the protein concentration was determined using the BCA assay. Equal amounts of protein were loaded onto the gel, followed by conventional gel preparation, loading, electrophoresis, and membrane transfer. The membrane was blocked with 5% BSA at room temperature and then incubated overnight with primary antibodies against MURF-1 (1:8000, Proteintech, 55456-1-AP), PGC-1α (1:1000, Abcam, ab54481), SIRT1 (1:2000, Abcam, ab110304), FGF21 (1:1000, Abcam, ab171941), OXCT (1:2000, Abcam, ab105320), HADH (1:1000, Huabio, R1411-4), CPT-1b (1:2000, Abcam, ab134988), and GAPDH (1:8000, Gene-protein Link, P01L01, ) at 4°C with gentle shaking. The following day, the membrane was washed three times with 1×TBST for 10-minute intervals, incubated with a secondary antibody (1:2000, ZSGB-BIO) at room temperature for 2 hours, washed again with 1×TBST, and exposed to ECL luminescent solution for detection. The protein gray values were analyzed using ImageJ software, with GAPDH serving as the internal reference. The relative expression level of the target protein was calculated as the ratio of the gray value of the target protein to that of GAPDH.
2.11. Quantitative Real-Time Polymerase Chain Reaction
Weigh 10 mg of soleus muscle tissue and add 1 mL of TRIzol reagent (Invitrogen, USA) to homogenize the sample. After separating the supernatant, add 200 µL of chloroform and mix thoroughly. Allow the mixture to stand at room temperature for 5 minutes, then centrifuge at 12,000 rpm at 4°C for 10 minutes to collect the aqueous phase. Add 500 µL of isopropanol and mix gently, then let the mixture stand at room temperature for 10 minutes. Centrifuge again at 12,000 rpm at 4°C for 10 minutes, discard the supernatant, and wash the RNA pellet with 1 mL of pre-cooled 75% ethanol. Centrifuge at 7,500 rpm at 4°C for 5 minutes, remove the supernatant, and allow the pellet to air-dry for 15 minutes to remove residual ethanol. Add an appropriate volume of DEPC-treated water to fully dissolve the RNA pellet and measure the RNA concentration. Genomic DNA was removed using the Master Mix Kit (Takara, RR047A), and RNA was reverse transcribed using the same kit. Quantitative RT-PCR was performed using TB-Green Premix Ex Tag (Takara, RR420A). The 18S rRNA gene was used as the internal reference, and relative mRNA expression was calculated using the 2
−ΔΔCt method. The RT-PCR primers used in this study are listed in
Table 1.
2.12. Histological Staining
For staining, the cryosections were blocked with 3% bovine serum albumin (BSA) in DPBS for 1 hour at room temperature, followed by incubation overnight at 4°C with a cocktail of primary antibodies, including MyHC I (BA-D5, DSHB, Iowa City, IA, USA), MyHC IIa (SC-71, DSHB), MyHC IIb (BF-F3, DSHB), and Laminin (ab11575, Abcam, Cambridge, UK). After washing, the cryosections were incubated with a cocktail of secondary antibodies, including Alexa Fluor 647-conjugated goat anti-mouse IgG2b (A21242), Alexa Fluor 568-conjugated goat anti-mouse IgG1 (A21124), Alexa Fluor 488-conjugated goat anti-mouse IgM (A21042), and Alexa Fluor 405-conjugated goat anti-rabbit IgG (A31556) (Thermo Fisher Scientific, Waltham, MA, USA), for 1 hour at room temperature. Images of the cryosections were acquired using a Leica Thunder Imager 3D Assay (Leica Application Suite X (LAS X) 3.6.0; Leica) and analyzed with ImageJ software.
2.13. Statistical Analysis
Statistical analysis was performed via GraphPad Prism 10.0 and SPSS 22.0 software. The experimental results are presented as the means ± standard deviations (means ± SD). After confirming a normal distribution, one-way analysis of variance (ANOVA) was employed for statistical analysis, with pairwise comparisons conducted via the least significant difference (LSD) method, and post hoc tests were performed via Duncan's multiple range test. A value of P < 0.05 was considered statistically significant.
4. Discussion
Research has demonstrated that ketogenic diets play a significant role in controlling body weight and preserving muscle mass. A study by Ogura et al. [
9] indicated that a 4-week ketogenic diet could prevent weight gain associated with aging, consistent with previous findings [
31,
32,
33,
34,
35,
36,
37,
38]. In the present study, using C57BL/6J mice as subjects, the results showed that from the second week onward, body weight gain in the KD group was lower than in the control diet group, aligning with findings from other studies [
39,
40,
41]. However, as the intervention period progressed, the body weight difference between the KD and control diet groups narrowed, suggesting that the mice developed keto-adaptation, leading to a phase-specific change in body weight. This trend contrasts with findings from Shimizu et al. [
42], Wallace et al. [
43], and Zhou et al. [
44], whose studies reported differing results. These discrepancies may be attributed to variations in intervention duration, muscle tissue types examined, and the protein content of the ketogenic diet.
There is currently a limited number of studies investigating the effects of ketogenic diets on mice under simulated weightlessness. It is well established that body weight, skeletal muscle wet weight, and the wet weight-to-body weight ratio are commonly used indicators to assess skeletal muscle atrophy in rodents. Additionally, MuRF-1 and Atrogin1 are widely recognized as markers of muscle atrophy [
45]. In the present study, a 2-week tail suspension intervention reduced body weight in the control diet group and led to a decrease in the wet weight-to-body weight ratio of the soleus muscle, accompanied by increased expression of MuRF-1 protein and Atrogin1 mRNA, indicating muscle atrophy in the soleus muscle. Following dietary and exercise interventions, we found that the ketogenic diet or the combination of ketogenic diet and exercise significantly downregulated MuRF-1 protein and Atrogin1 mRNA expression, thereby inhibiting muscle atrophy in the soleus muscle. Interestingly, in the absence of simulated weightlessness, the ketogenic diet provided better protection for the soleus muscle, helping to maintain muscle mass. However, due to the limited number of related studies, there is a lack of robust experimental data to support these findings, and further research is necessary to confirm these results.
Reduced skeletal muscle usage triggers an adaptive metabolic remodeling, characterized by a decrease in fat oxidation capacity and a shift towards glycolysis as the primary fuel source, accompanied by a transition in myosin heavy chain (MHC) fiber types from slow-twitch to fast-twitch fibers[
46,
47]. As a result, fast-twitch glycolytic fibers are more susceptible to atrophy than slow-twitch oxidative fibers [
48]. In this study, we observed that after the tail suspension intervention, the NH group mice exhibited a significant decrease in the proportion of MHC-I fibers and a marked increase in the proportion of MHC-IIb fibers, leading to a decline in their exercise capacity. The KD induced a transition of skeletal muscle fibers from MHC-IIb to MHC-I[
9,
43,
49,
50,
51]. These findings suggest that, in the KD group, skeletal muscles may undergo a shift towards a slow-twitch fiber phenotype, potentially protecting the muscles from fiber loss associated with frailty (muscle degeneration). Furthermore, the reduction in MHC-IIb isoform levels due to exercise training is associated with enhanced muscle aerobic capacity [
52,
53,
54]. Our study confirmed that the combined intervention of KD and exercise was significantly more effective than aerobic exercise alone. This combined approach significantly alleviated the muscle fiber type transformation induced by simulated weightlessness, thereby improving the exercise performance of the KD + Exercise (KHE) group mice. This result was further corroborated by the exhaustive one-time exercise test. Notably, PGC-1α [
14,
15,
16,
17] is a key regulatory molecule in skeletal muscle, involved in regulating oxidative metabolism, fatty acid oxidation, and the transition between fast and slow muscle fiber types. Additionally, PGC-1α regulates the expression of ketolytic enzymes and ketone body transporters in skeletal muscle, significantly influencing systemic ketosis [
18]. Further investigation revealed that the FGF21-SIRT1-AMPK-PGC-1α signaling pathway promotes myocyte differentiation and the conversion of anaerobic muscle fibers to an oxidative phenotype [
19]. The immunofluorescence staining results of this study confirmed the impact of changes in protein expression associated with fiber type transitions. KD increased the expression of PGC-1α, SIRT1, and FGF21 in the soleus muscle, which led to a significant increase in the proportion of MHC-I fibers compared to the control group. Conversely, the proportion of MHC-IIb fibers, representing fast-twitch fibers, was significantly reduced. However, a pure KD alone did not counteract the tail suspension-induced changes in soleus muscle fiber types. The KH group showed a shift from slow to fast fibers, a result that negatively impacted the aerobic endurance of the mice, as reflected in the exhaustive exercise test outcomes.
In contrast to the early-phase weight gain suppression observed with ketogenic diet (KD), KD intake did not cause significant changes in blood glucose levels. Despite an extremely low carbohydrate intake, blood glucose remained stable, likely due to compensatory mechanisms such as enhanced gluconeogenesis, glycogenolysis, and inhibited glucose uptake, which help maintain glucose homeostasis [
55]. In this study, no significant changes in blood glucose concentrations were observed across the experimental groups, further supporting this hypothesis. Additionally, muscle glycogen serves as a key energy source for fast-twitch muscles (e.g., EDL). After four weeks of KD feeding, glycogen content remained unchanged [
56]. Conversely, K et al. [
55] reported a reduction in muscle glycogen content in mice after four weeks on a ketogenic diet. In our study, no significant changes in glycogen content were observed in the soleus muscle of the KD or KD combined intervention groups, although lipid droplet content significantly increased. This may be attributed to daily exercise training, which could have offset the reduction in muscle glycogen storage [
55]. Following a pure ketogenic diet (KD), increased levels of free fatty acids in the blood and lipid droplets in skeletal muscle led to a significant upregulation of enzymes such as CPT-1b and HADH, which facilitate fatty acid oxidation in skeletal muscle [
57]. As the β-oxidation process intensified, the NAD+ content produced during oxidation also significantly increased, thereby activating the expression of SIRT1. SIRT1, in turn, activates the expression of PGC-1α through acetylation [
58]. The activation of factors such as PGC-1α and SIRT1 not only positively regulates the expression of lipid metabolism enzymes like CPT-1b and HADH [
59,
60], but also promotes the conversion of muscle fibers from fast-twitch to slow-twitch through the FGF21-SIRT1-AMPK-PGC-1α signaling pathway [
19]. This may counteract the shift from slow to fast muscle fibers induced by tail suspension, potentially increasing the proportion of slow-twitch fibers in skeletal muscle. With the increase in slow-twitch fibers and the continued KD regimen, lipid droplet content in the muscle was further elevated, which is essential for improving aerobic capacity al., 2020). These lipid droplets, as a critical energy source for muscle metabolism, can effectively enhance aerobic endurance [
61].
Moreover, the expression of CPT-1b and HADH in the soleus muscle was significantly increased, reflecting the cumulative effects of fiber type changes and the activation of PGC-1α and other proteins. This combination of changes led to a substantial increase in fat metabolism in the ketogenic diet (KD) group mice. Simultaneously, aerobic capacity was enhanced along with ketone body production [
62,
63]. In the liver, ketone bodies were produced in large quantities and circulated into the bloodstream, reaching skeletal muscle. During this period, the expression of the key rate-limiting enzyme in ketolysis, OXCT, was upregulated in skeletal muscle under the influence of PGC-1α, further promoting ketone body breakdown and their participation in energy metabolism via the tricarboxylic acid cycle [
64]. It is also important to note that, for mice subjected to combined KD and aerobic exercise interventions, despite significant alterations in fat and ketone body metabolism, muscle glycogen levels and blood glucose concentrations remained relatively stable (with a slight reduction). This stability likely supports prolonged exercise capacity. Overall, this adaptive metabolic model in skeletal muscle—primarily reliant on ketone body metabolism, with significant increases in fat metabolism and stable glucose metabolism—effectively enhanced aerobic endurance.
Figure 1.
Schematic overview of experimental design.
Figure 1.
Schematic overview of experimental design.
Figure 2.
Successful establishment of the ketogenic diet mouse model. (A) Weekly changes in mouse body weight. (B) Weekly variations in blood ketone levels. (C) Weekly fluctuations in blood glucose levels. (D) Changes in the respiratory exchange ratio. The data are presented as the means ± SD. *P < 0.05, **P < 0.01, compared with the normal diet control group. NC: normal diet control group; KC: ketogenic diet control group; RER: respiratory exchange ratio.
Figure 2.
Successful establishment of the ketogenic diet mouse model. (A) Weekly changes in mouse body weight. (B) Weekly variations in blood ketone levels. (C) Weekly fluctuations in blood glucose levels. (D) Changes in the respiratory exchange ratio. The data are presented as the means ± SD. *P < 0.05, **P < 0.01, compared with the normal diet control group. NC: normal diet control group; KC: ketogenic diet control group; RER: respiratory exchange ratio.
Figure 3.
Effect of the ketogenic diet on weightlessness model mice. (A) Body weight fluctuations in the mice before and after the hindlimb unloading. (B) Ratio of soleus muscle wet weight to body weight across groups. (C) Representative western blot images of MuRF-1. (D) Protein expression of MuRF-1 in the soleus muscle. mRNA expression of MuRF-1 (E), Atrogin1 (F) in the soleus muscle. The data are presented as the means ± SD. aP < 0.05, aaP < 0.01 compared with before HU; *P < 0.05, **P < 0.01 compared with the control group; #P < 0.05, ##P < 0.01 compared with the diet groups. BW: body weight; NC: normal diet control group; NH: normal diet + hindlimb unloading group; NHE: normal diet + hindlimb unloading + exercise group; KC: ketogenic diet control group; KH: ketogenic diet + hindlimb unloading group; KHE: ketogenic diet + hindlimb unloading + exercise group.
Figure 3.
Effect of the ketogenic diet on weightlessness model mice. (A) Body weight fluctuations in the mice before and after the hindlimb unloading. (B) Ratio of soleus muscle wet weight to body weight across groups. (C) Representative western blot images of MuRF-1. (D) Protein expression of MuRF-1 in the soleus muscle. mRNA expression of MuRF-1 (E), Atrogin1 (F) in the soleus muscle. The data are presented as the means ± SD. aP < 0.05, aaP < 0.01 compared with before HU; *P < 0.05, **P < 0.01 compared with the control group; #P < 0.05, ##P < 0.01 compared with the diet groups. BW: body weight; NC: normal diet control group; NH: normal diet + hindlimb unloading group; NHE: normal diet + hindlimb unloading + exercise group; KC: ketogenic diet control group; KH: ketogenic diet + hindlimb unloading group; KHE: ketogenic diet + hindlimb unloading + exercise group.
Figure 4.
Effects of the KD and KD combined with exercise on skeletal muscle tissue in mice. PAS (A) and Oil Red O (B) staining of the soleus muscle. Percentage of PAS (C) and Oil Red O (D) -stained area in the soleus muscle. Changes in blood ketone (E) and blood glucose (F) levels before and after a single exhaustive exercise in each group of mice. The data are presented as the means ± SD. *P < 0.05, **P < 0.01 compared between diet groups; #P < 0.05, ##P < 0.01 compared within diet groups.
Figure 4.
Effects of the KD and KD combined with exercise on skeletal muscle tissue in mice. PAS (A) and Oil Red O (B) staining of the soleus muscle. Percentage of PAS (C) and Oil Red O (D) -stained area in the soleus muscle. Changes in blood ketone (E) and blood glucose (F) levels before and after a single exhaustive exercise in each group of mice. The data are presented as the means ± SD. *P < 0.05, **P < 0.01 compared between diet groups; #P < 0.05, ##P < 0.01 compared within diet groups.
Figure 5.
Effects of a KD or KD combined with exercise on muscle fiber composition in the soleus muscles of mice. Representative immunofluorescence images of MHC-I (blue, A), MHC-IIa (red, B), MHC-IIb (green, C) muscle fibers in the soleus muscle. The proportion of MHC-I (D), MHC-IIa (E), MHC-IIb (F) muscle fibers in the soleus muscle. The data are presented as the means ± SD. *P < 0.05, **P < 0.01 indicate comparisons between diet groups; #P < 0.05, ##P < 0.01 indicate comparisons within each diet group.
Figure 5.
Effects of a KD or KD combined with exercise on muscle fiber composition in the soleus muscles of mice. Representative immunofluorescence images of MHC-I (blue, A), MHC-IIa (red, B), MHC-IIb (green, C) muscle fibers in the soleus muscle. The proportion of MHC-I (D), MHC-IIa (E), MHC-IIb (F) muscle fibers in the soleus muscle. The data are presented as the means ± SD. *P < 0.05, **P < 0.01 indicate comparisons between diet groups; #P < 0.05, ##P < 0.01 indicate comparisons within each diet group.
Figure 6.
Effects of a ketogenic diet or ketogenic diet combined with exercise on skeletal muscle protein and mRNA expression. Representative western blot images of PGC-1α, SIRT1, FGF21 (A) and CPT-1b, OXCT, HADH (H). Protein expression of PGC-1α (B), SIRT1 (C), FGF21 (D) and CPT-1b (I), OXCT (J), HADH (K) in the soleus muscle. mRNA expression of PGC-1α (E), SIRT1 (F), FGF21 (G) and CPT-1b (L), OXCT (M), HADH (N) in the soleus muscle. The data are presented as the means ± SD. *P < 0.05, **P < 0.01, denoting comparisons between diet groups; #P < 0.05, ##P < 0.01, reflecting comparisons within diet groups.
Figure 6.
Effects of a ketogenic diet or ketogenic diet combined with exercise on skeletal muscle protein and mRNA expression. Representative western blot images of PGC-1α, SIRT1, FGF21 (A) and CPT-1b, OXCT, HADH (H). Protein expression of PGC-1α (B), SIRT1 (C), FGF21 (D) and CPT-1b (I), OXCT (J), HADH (K) in the soleus muscle. mRNA expression of PGC-1α (E), SIRT1 (F), FGF21 (G) and CPT-1b (L), OXCT (M), HADH (N) in the soleus muscle. The data are presented as the means ± SD. *P < 0.05, **P < 0.01, denoting comparisons between diet groups; #P < 0.05, ##P < 0.01, reflecting comparisons within diet groups.
Table 1.
Description of primers used for quantitative real-time PCR.
Table 1.
Description of primers used for quantitative real-time PCR.
Gene Name |
Forward Primer |
Reverse Primer |
Atrogin1 |
5′-TCAGCAGCCTGAACTACGAC -3′ |
5′-GCGCTCCTTCGTACTTCCTT -3′ |
MURF-1 |
5’-GTGTGAGGTGCCTACTTGCT-3’ |
5’-GACTTTTCCAGCTGCTCCCT-3’ |
PGC-1α |
5′- AGCCGTGACCACTGACAACGAG-3′ |
5′- GCTGCATGGTTCTGAGTGCTAAG-3′ |
SIRT1 |
5′- TACCTTGGAGCAGGTTGCAG-3′ |
5′- GCACCGAGGAACTACCTGAT-3′ |
FGF21 |
5′- GCATACCCCATCCCTGACTC-3′ |
5′- GGATCAAAGTGAGGCGATCC-3′ |
CPT-1b |
5′-TTCAACACTACACGCATCCC-3′ |
5′-GCCCTCATAGAGCCAGACC-3′ |
HADH |
5′-ACACCTTCATTCGCCATATTGC-3′ |
5′-TCGGTGAATTTTCTGTAGACCAC-3′ |
OXCT |
5′-CCCATACCCACTGAAAGACGAA-3′ |
5′- CTGGAGAAGAAAGAGGCTCCTG-3′ |
18s |
5′-GGGAGCCTGAGAAACGGC-3′ |
5′-GGGTCGGGAGTGGGTAATTT-3′ |
Table 2.
Plasma metabolic parameters.
Table 2.
Plasma metabolic parameters.
|
TC (mmol/L) |
TG (mmol/L) |
HDL-C (mmol/L) |
LDL-C (mmol/L) |
UREA (mmol/L) |
Insulin (ng/mL) |
NC |
1.35 ± 0.15 |
0.38 ± 0.07 |
1.18 ± 0.09 |
0.17 ± 0.03 |
9.57 ± 0.37 |
0.97 ± 0.21 |
NH |
1.29 ± 0.23 |
0.58 ± 0.18 |
1.12 ± 0.13 |
0.18 ± 0.06 |
9.28 ± 0.34 |
1.72 ± 0.58##
|
NHE |
1.24 ± 0.21 |
0.59 ± 0.29 |
1.09 ± 0.21 |
0.20 ± 0.06 |
8.33 ± 0.30 |
1.44 ± 0.56##
|
KC |
2.16 ± 0.20**
|
0.63 ± 0.20**
|
1.90 ± 0.12**
|
0.27 ± 0.04**
|
9.31 ± 0.80**
|
1.51 ± 0.59*
|
KH |
1.96 ± 0.23#**
|
0.99 ± 0.16##**
|
1.64 ± 0.27##**
|
0.25 ± 0.03**
|
9.53 ± 0.85**
|
1.38 ± 0.51**
|
KHE |
1.79± 0.36##**
|
0.74 ± 0.29#
|
1.55 ± 0.38##**
|
0.23 ± 0.03##
|
9.25 ± 0.42**
|
1.65 ± 0.71**
|
Table 3.
The effects of exercise capacity in mice.
Table 3.
The effects of exercise capacity in mice.
|
LD (mmol/L) |
UREA (mmol/L) |
CK (U/L) |
LDH (U/L) |
Time (min) |
NC |
1.81±0.26 |
9.57±0.37 |
850±310 |
513±166 |
136 ± 15 |
NH |
2.41±0.53##
|
9.27±0.34 |
866±260 |
655±97 |
83 ± 24##
|
NHE |
2.32±0.34##
|
8.33±0.30 |
749±275 |
547±113 |
84 ± 30##
|
KC |
2.43±0.39**
|
9.20±0.71 |
981±233 |
521±180 |
152 ± 18 |
KH |
2.23±0.46 |
9.26±0.61 |
863±315 |
615±272 |
81 ± 36##
|
KHE |
2.03±0.34##
|
9.26±0.49 |
955±288 |
486±286 |
136 ± 26##*
|